These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4875710)

  • 21. Diazoxide and the secretion of insulin.
    Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
    [No Abstract]   [Full Text] [Related]  

  • 22. Improvement in insulin secretion in diabetes after diazoxide.
    Greenwood RH; Mahler RF; Hales CN
    Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE EFFECT OF A BENZOTHIADIAZINE, DIAZOXIDE, ON CARBOHYDRATE METABOLISM.
    TABACHNICK II; GULBENKIAN A; SEIDMAN F
    Diabetes; 1964; 13():408-18. PubMed ID: 14210687
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine.
    Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M
    Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans.
    Quesada I; Nadal A; Soria B
    Diabetes; 1999 Dec; 48(12):2390-7. PubMed ID: 10580428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of hydrocortisone treatment and adrenalectomy on insulin and glucagon secretion from the perfused rat pancreas.
    Lenzen S
    Endokrinologie; 1976; 68(2):189-97. PubMed ID: 795635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin secretion studied in the perfused rat pancreas. I. Effect of tolbutamide, leucine and arginine; their interaction with diazoxide, and relation to glucose.
    Basabe JC; Lopez NL; Viktora JK; Wolff FW
    Diabetes; 1971 Jul; 20(7):449-56. PubMed ID: 5556282
    [No Abstract]   [Full Text] [Related]  

  • 28. Stimulation of insulin secretion by the C-terminal tetrapeptide amide of gastrin.
    Kaneto A; Tasaka Y; Kosaka K; Nakao K
    Endocrinology; 1969 May; 84(5):1098-106. PubMed ID: 4887861
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin and glucagon release from isolated islets of Langerhans. Effect of enteric factors.
    Buchanan KD; Vance JE; Williams RH
    Diabetes; 1969 Jun; 18(6):381-6. PubMed ID: 4892443
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
    Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
    Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical aspects of the hyperglycemic action of diazoxide.
    Senft G
    Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of diazoxide inhibition of insulin secretion as a tool to investigate insulin stimulation by other agents.
    Gulbenkian A; Ornstein L; Tabachnick II
    Horm Metab Res; 1972 Mar; 4(2):57-8. PubMed ID: 5028220
    [No Abstract]   [Full Text] [Related]  

  • 34. Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets.
    Lebrun P; Devreux V; Hermann M; Herchuelz A
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1011-8. PubMed ID: 2506332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FURTHER OBSERVATIONS CONCERNING THE HYPERGLYCEMIC ACTIVITY OF BENZOTHIADIAZINES.
    WOLFF FW; PARMLEY WW
    Diabetes; 1964; 13():115-21. PubMed ID: 14127422
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sulfonamides modifying insulin secretion and the development of the islands of Langerhans. Actions and antagonisms of actions. Some experimental studies of their clinical applications].
    Loubatières A; Mariani MM; Alric R
    Bull Acad Natl Med; 1967 Dec; 151(33):683-94. PubMed ID: 4866937
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system.
    Porte D; Robertson RP
    Fed Proc; 1973 Jul; 32(7):1792-6. PubMed ID: 4352448
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of HB 419 and tolbutamide on isolated islands of Langerhans in rats].
    Löffler G; Trautschold I; Schweitzer T; Lohmann E
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1469-72. PubMed ID: 4899090
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
    Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
    Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
    Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.